603 is a clinical research site located in West Seneca, New York, United States.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
603 has participated in 1 clinical trials.
Therapeutic areas: Restless Legs Syndrome, End-Stage Renal Disease.
Sponsors: UCB BIOSCIENCES GmbH.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
603 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
603 has 1 clinical trials on record. Their work covers Restless Legs Syndrome, End-Stage Renal Disease.
603 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.